ADC Therapeutics SA Form 6-K Summary
Reporting period: Form 6-K filed October 9, 2020, covering the month of October 2020. ADC Therapeutics SA is a Swiss foreign private issuer filing annual reports on Form 20-F.
Filing contents
The filing consists of the Form 6-K cover page and references Exhibit 99.1, a press release dated October 9, 2020. The provided filing text does not include the press release itself.
Financial and operating information
The provided text does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, guidance, or other operating metrics.
Material changes, outlook, and risks
The filing text does not describe material changes versus a prior period, management commentary, outlook, contingencies, risks, or unusual items.
Investor verification items
- Obtain and review Exhibit 99.1, the October 9, 2020 press release.
- Verify whether the press release contains financial results, clinical or regulatory updates, financing information, guidance, or material risk disclosures.
- Confirm any information in the press release against ADC Therapeutics SA’s subsequent Form 20-F and other SEC filings.